Navigation Links
Epsen Fuller Group Recruits Operations Leader for Global Biotech Firm SOTIO
Date:4/11/2013

NEW YORK, April 11, 2013 /PRNewswire-iReach/ -- SOTIO a.s, a leader in cell therapy treatments for cancer and autoimmune diseases, has added to their senior leadership team with the addition of Heidi M. Hagen as Chief Operating Officer-US and Head of Global Operations Strategy. As the strategic advisor to SOTIO, Epsen Fuller Group completed the successful placement, which encompassed an exhaustive search of the top operational leaders in biotechnology, and specifically cell manufacturing.

(Photo: http://photos.prnewswire.com/prnh/20130411/CG92806)

"This role is very narrowly focused on cutting-edge therapies based on activated dendritic cells that trigger the immune system for the treatment of cancer and autoimmune diseases", explained Thomas Fuller , Managing Partner of Epsen Fuller Group and leader on his project.

Ms. Hagen is an expert in dendritic cell manufacturing and autologous operations as evidenced in her most recent role as SVP, Operations at Dendreon. Heidi's achievements there were numerous, including building three state-of-the-art, and very high-performing manufacturing facilities, on budget and on schedule. Heidi was formerly at Immunex Corporation, acquired by Amgen, where she held leadership positions in supply chain, clinical operations, and business strategy. Holding an MBA, an MS in Bioengineering, and a BS in cell and molecular biology, all from the University of Washington, Heidi is a widely-recognized authority on cell manufacturing.

"Sotio is focused on becoming a leader in the field of modern biotechnology therapies and related science," says Mr. Fuller. "We were looking for an individual with the real drive and passion to lead the way in commercializing the science of cell manufacturing, thereby enabling SOTIO to flourish as an innovative and fast-growth organization and reinforce its commitment to connecting patients and science."

About SOTIO

SOTIO Group is a biotechnology group developing new therapies based on activated dendritic cells, focusing on the treatment of cancer and autoimmune diseases. Its mission is to develop new medical therapies using SOTIO's proprietary cell-based technologies to treat highly unmet medical conditions using SOTIO's immunotherapy platform. World renowned scientists are working at SOTIO's research facilities in Prague using state-of-the art technologies to understand the role of dendritic cells in the therapeutic activation of the body's immune response. SOTIO plans to start a global pivotal Phase 3 clinical trial which will enroll U.S. as well as E.U. patients under the supervision of FDA and EMA. SOTIO, LLC is an affiliate of SOTIO and is responsible for organizing SOTIO Group's activities in the United States.

About Epsen Fuller Group

New York based Epsen Fuller Group, www.epsenfuller.com, is a Top-20 retained executive search and talent management consulting firm with US offices in New York, New Jersey and San Francisco and offices in major markets and business centers throughout the world, providing instant access to a world-class executive talent pool serving the global economy.

Epsen Fuller Group delivers an integrated suite of talent management solutions throughout four business units focused on the acquisition, assessment, and acceleration of talent. EF|IMD conducts senior executive search, TalentKinect executes mid-management recruitment projects, iDestiny offers a variety of leadership assessment, development, and coaching solutions, while EFAdvisory delivers talent assessment and advisory services to enhance governance best practices in corporate Boards and maximize transaction value for Private Equity Groups. The firm specializes in three industry verticals – consumer, life sciences, and the tech|communications|media sectors - placing top talent in blue-chip client organizations worldwide.

Media Contact:

Kate Hassey , Epsen Fuller Group, 2123924842, khassey@epsenfuller.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Epsen Fuller Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Groupe Athena, Inc. Releases 3rd Quarter Financials, Continues Strong Revenue And Earnings Growth
2. Equatorial Guineas [EG] Ministry of Health convenes in Washington, DC with GB Group Global and TNI Biotech (OTCBB:TNIB) to launch major innovative health solutions and improve pharmaceutical quality for its citizens
3. Digital Marketing Groups Growing, Evolving to Respond to Tumultuous Marketing Landscape
4. DFH Pharma, USA Partners with Hetero Group, INDIA to Develop 2nd Generation HIV Maturation Inhibitor Drugs
5. Simcere Pharmaceutical Group Announces its Special Committees Engagement of Financial Advisor
6. Chimerixs Antiviral CMX001 Abstract Selected for an Oral Presentation at the European Group for Blood and Marrow Transplantations Annual Meeting
7. Fortune Magazine Profiles ArcView Group, Co-founded by Steve DeAngelo
8. Bio-pharma Internal Communications Groups Evolving for Structure Optimization
9. Simcere Pharmaceutical Group Announces Issuance of GMP Certificate to Simcere Vaxtec
10. Millennium Research Group Sponsors Case Competition at Western University for Second Year
11. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... 2016  Alopexx Oncology, LLC announced data from a ... protein (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal ... B cells as Rituxan and maintains the activities of ... involved in tumor targeting, engagement of the immune system, ... of the study (abstract #95954) were presented at the ...
(Date:12/6/2016)... Homozygous Familial Hypercholesterolemia (HoFH) - ... Global Markets Direct,s latest Pharmaceutical and Healthcare ... – Pipeline Review, H2 2016, provides an ... (Metabolic Disorders) pipeline landscape. Homozygous familial ... caused due to mutation from both parents. ...
(Date:12/6/2016)... 2016   AlloSource , one of the ... and soft-tissue allografts for use in surgical procedures, ... for being named to the Board of Examiners ... by the Commerce Department,s National Institute of Standards ... process excellence. The Baldrige Award is the nation,s ...
Breaking Medicine Technology:
(Date:12/7/2016)... ... December 07, 2016 , ... A quote from Dr. ... of comments on social media that offer a rare glimpse into the mind of ... authority and New York Times bestselling author, has described people with ADHD as having ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... consultation services from offices located in South Lyon, Dewitt, Williamston, East Lansing, Ann ... basketball coach who needs treatment for a brain tumor. , Jason Bauer and ...
(Date:12/7/2016)... ... 07, 2016 , ... A. Kevin Spann Insurance, a New York-based firm offering ... is launching a charity drive to raise funds that will benefit the Marine Corps ... marines and Navy FMF Corpsmen. Working closely with the MCL, the A. Kevin Spann ...
(Date:12/7/2016)... ... December 07, 2016 , ... Delete® - Tattoo Removal and ... The Holiday Party Season. Save Up To 33% Off Botox® and Juvederm® Products Now ... the Phoenix Valley with Delightful Deals on Botox® and Juvederm® just in ...
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite is ... Awards under the Best New Product Launch category. Gensuite’s entry on their EZ ... , BOC Global Events & Training Group is a professional event and training ...
Breaking Medicine News(10 mins):